Xgen Venture

Xgen Venture company information, Employees & Contact Information

Updated May 2026

Quick answer

Xgen Venture is a Venture Capital and Private Equity Principals company and founded in 2021. It has approximately 21 employees on record. Contact data was last refreshed in May 2026. Find Xgen Venture's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

XGEN Venture is a venture capital fund manager established in 2021 by the former Genextra team, that specializes in life science investing. We work with a group of exceptional scientists and entrepreneurs to translate high level science into solutions for patients.

Company Details

Employees
21
Founded
2021
Address
Milan, It
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
Keywords
Paris.
HQ
Milan
Looking for a particular Xgen Venture employee's phone or email?

Xgen Venture Questions

News

XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund - Business Wire

XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund Business Wire

XGEN Venture: €180 Million Life Sciences Fund Closes - Pulse 2.0

XGEN Venture: €180 Million Life Sciences Fund Closes Pulse 2.0

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms - Fierce Biotech

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms Fierce Biotech

Italy’s angels & incubators and venture capital weekly roundup. News from Nanophoria, XGEN Venture, Sofinnova Partners, CDP Venture Capital, Ventive, Vanguard Legacy Capital, Redstone, KON Group, Lorenzo Guidotti, FundX – Fabio Nalucci, and more - BeBeez International

Italy’s angels & incubators and venture capital weekly roundup. News from Nanophoria, XGEN Venture, Sofinnova Partners, CDP Venture Capital, Ventive, Vanguard Legacy Capital, Redstone, KON Group, Lorenzo Guidotti, FundX – Fabio Nalucci, and more BeBeez International

Genespire raises €46.6 million (~$52 million) in a Series B - GlobeNewswire

Genespire raises €46.6 million (~$52 million) in a Series B GlobeNewswire

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform - Business Wire

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform Business Wire

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant